This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Zhichen Xu: Innovator in HPV Detection Technology
Introduction
Zhichen Xu is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of human papillomavirus (HPV). His innovative work has the potential to enhance screening processes and improve public health outcomes.
Latest Patents
Zhichen Xu holds a patent for a "Multiplexed nucleic acid detection kit for human papilloma virus (HPV) typing." This multi-target nucleic acid detection kit includes a recombinase polymerase amplification (RPA) primer set, an enzyme, and a buffer system for Cas12a-crRNA, along with a reporter molecule that displays a signal. The detection method utilizes a multi-channel microfluidic chip as a carrier, allowing for isothermal amplification of different HPV subtypes. The crRNA set is designed for amplicons of various subtypes, enabling accurate detection of HPV targets in samples. This method demonstrates high sensitivity, low cost, and ease of operation, making it suitable for widespread use in HPV infection screening.
Career Highlights
Zhichen Xu is affiliated with the Chinese Academy of Sciences, where he has been involved in groundbreaking research and development. His work has garnered attention for its innovative approach to HPV detection, contributing to advancements in medical diagnostics.
Collaborations
Zhichen Xu has collaborated with notable colleagues, including Yunhuang Yang and Tao Li. Their combined expertise has furthered the development of effective diagnostic tools in the field of virology.
Conclusion
Zhichen Xu's contributions to HPV detection technology exemplify the impact of innovation in medical diagnostics. His work not only enhances the accuracy of HPV screening but also holds promise for improving public health initiatives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
